Aurora Cannabis Inc. (ACB) Earnings Call Analysis

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

19/25

Growth 5 Margin 5 Expansion 3 Platform 3 Financial 3

latest quarter score

Earnings Reports

19
Aurora Cannabis (ACB) Q1 2027: International Medical Revenue Jumps 17% as EU GMP Expansion Accelerates
August 05, 2026
19
Aurora Cannabis (ACB) Q3 2026: Medical Cannabis Hits 81% of Revenue as Global Focus Deepens
June 15, 2026
11
Aurora Cannabis (ACB) Q4 2026: International Medical Cannabis Surges to 58% of Revenue as Canada Reimbursement Cuts Bite
June 11, 2026
20
Aurora Cannabis (ACB) Q2 2026: Medical Margins Hit 69% as International Revenue Climbs 22%
November 05, 2025
20
Aurora Cannabis (ACB) Q1 2026: Global Medical Revenue Soars 85% as International Expansion Drives Margin Upside
August 06, 2025
21
ACB Q4 2025: Medical Cannabis Revenue Jumps 48% as International Margins Expand
July 02, 2025
Aurora Cannabis (ACB) Q2 2025: International Medical Cannabis Revenue Jumps 93% as Global Shift Accelerates
November 06, 2024
Aurora Cannabis (ACB) Q1 2025: Medical Cannabis Margins Hit 69% as Global Expansion Accelerates
August 07, 2024
Aurora Cannabis (ACB) Q4 2024: Medical Cannabis Margins Hit 66% as Global Expansion Accelerates
June 20, 2024
Aurora Cannabis (ACB) Q3 2024: International Medical Revenue Jumps 41% as Australia Acquisition Reshapes Global Footprint
February 08, 2024
Aurora Cannabis (ACB) Q2 2024: Medical Revenue Jumps 42% as International Expansion Drives Margin Strength
November 09, 2023
Aurora Cannabis (ACB) Q1 2024: Bevo Propagation Up 85%, Diversification Accelerates Cash Flow Path
August 10, 2023
Aurora Cannabis (ACB) Q3 2023: $40M Cost Target Sharpens Path to Free Cash Flow
June 14, 2023

Browse all companies